Patents Assigned to Infinitus (China) Company Ltd.
  • Publication number: 20240102111
    Abstract: The present invention relates to a molecular marker, a specific primer pair, and an identification method of the high-quality Ganoderma lucidum strain HMGIM-M624. The high-quality Ganoderma lucidum strain HMGIM-M624 was preserved in Guangdong Microbial Culture Collection Center (address: 5th Floor, No. 59 Building of No. 100 Yard, Mid. Xianlie Road, Guangzhou City) with the preservation number of GDMCC No: 60889 on Nov. 7, 2019. The molecular marker is an InDel molecular marker. The high-quality Ganoderma lucidum strain HMGIM-M624 has a base deletion of CATGCTGTA at the 246451th-246460th site of the chromosome sca34. The present invention provides reagents for detecting the molecular marker of the high-quality Ganoderma lucidum strain HMGIM-M624. The reagents can distinguish the high-quality Ganoderma lucidum strain HMGIM-M624 from the other 11 G. lucidum strains for commercial cultivation, thus specifically identifying the high-quality Ganoderma lucidum strain HMGIM-M624.
    Type: Application
    Filed: December 15, 2022
    Publication date: March 28, 2024
    Applicants: INFINITUS (CHINA) COMPANY LTD., INSTITUTE OF MICROBIOLOGY, GUANGDONG ACADEMY OF SCIENCES (GUANGDONG DETECTION CENTER OF MICROBIOLOGY
    Inventors: Xiuying KOU, Xiaoxian WU, Jian TANG, Qingping WU, Huiping HU, Xiaowei LIANG, Manjun CAI, Yizhen XIE, Yuanchao LIU, Lijun ZHUO, Ao WANG, Na DU
  • Patent number: 11925669
    Abstract: Herbal composition having an effect of reducing uric acid, which is made from the following herbal materials in specified portions by weight: 4-30 portions of Glabrous greenbrier rhizome, 2-15 portions of Chicory, 2-15 portions of Herba Plantaginis, 2-20 portions of Coix seed, and 2-10 portions of Kudzuvine Root. The composition may be used in combination with modern Western medicines to achieve optimal effects.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: March 12, 2024
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Xiaofei Xu, Xiaolei Guo, Chungwah Ma, Bin Shi, Zhen Luo
  • Patent number: 11779625
    Abstract: The invention relates to the field of health food technologies, and particularly to a composition and an application thereof in preparing a product for protecting mitochondria. The invention provides a composition, the raw materials of which include Haematococcus pluvialis, Lycium ruthenicum, Cordyceps militaris and nicotinamide. The composition has the effects of improving an oxidative stress level under a mitochondrial dysfunction and delaying mitochondrion-related aging. Compared with a single constituent, constituents in the composition cooperate with each other to produce a synergistic effect, which significantly improves an effect of protecting a mitochondrial function.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: October 10, 2023
    Assignee: Infinitus (China) Company Ltd.
    Inventors: Ying Zhang, Yiting Yang, Jian Tang, Jiaoyan Ren, Min Wang
  • Publication number: 20230310527
    Abstract: A Chinese herbal medicine composition for improving hearing impairment comprises at least two of avocado extract, ecklonia cava extract and perilla extract. The Chinese herbal medicine composition can effectively reduce a NO content secreted by cells, reduce an inflammatory reaction of cells, and have a good effect of improving LPS-induced hearing loss. Moreover, ingredients of the Chinese herbal medicine composition are medicine-and-food homologous ingredients, which have no obvious cytotoxicity and obvious side effects.
    Type: Application
    Filed: June 17, 2022
    Publication date: October 5, 2023
    Applicant: Infinitus (China) Company Ltd.
    Inventors: Yaqian GAO, Yiting YANG, Xiaochun XIAO, Zhiyun DU, Shijing MA, Li LIN
  • Publication number: 20230119836
    Abstract: The invention discloses a Chinese herbal medicine composition for relieving hearing loss and a preparation method and use thereof. The Chinese herbal medicine composition is prepared from at least two of the medicinal and edible raw materials of rhizoma curcumae longae, Dendrobium nobile and fructus Piperis longi, can effectively reduce the content of NO secreted by cells, reduces cell inflammation, and has a good effect of relieving hearing loss induced by LPS. The Chinese herbal medicine composition is not a simple combination of traditional Chinese medicines and has a synergistic effect. The Chinese herbal medicine composition can significantly reduce ABR value, MDA, and glutamic acid of a patient with hearing loss, significantly relieves hearing loss, and can be developed into functional foods and medicines for relieving hearing loss as an active ingredient.
    Type: Application
    Filed: January 6, 2022
    Publication date: April 20, 2023
    Applicant: Infinitus (China) Company Ltd.
    Inventors: Yaqian GAO, Jian TANG, Yiting YANG, Xiaochun XIAO, Zhiyun DU, Shijing MA, Li LIN
  • Patent number: 11517606
    Abstract: The present invention relates to a composition having an anti-glycation effect and an application thereof. The anti-glycation composition includes the following constituents in parts by mass: 0.1 to 5 parts of Osmanthus fragrans extract, 0.1 to 5 parts of Punica granatum extract and 0.1 to 2 part of Olea europaea extract, wherein in the Osmanthus fragrans extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of verbascoside is more than or equal to 10%; in the Punica granatum extract, a mass content of polyphenol is more than or equal to 30%, and a mass content of punicalagin is more than or equal to 8%; and in the Olea europaea extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of hydroxytyrosol is more than or equal to 3%.
    Type: Grant
    Filed: December 11, 2019
    Date of Patent: December 6, 2022
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Xiaoling Wang, Huawei Zhu, Zhen Luo, Jian Tang
  • Patent number: 11446342
    Abstract: The present disclosure relates to the field of microbial technology, and discloses a composite probiotics and the use thereof. The composite probiotics in the present disclosure is consisted of Bifidobacterium adolescentis CCFM8630, Lactobacillus reuteri CCFM8631, Lactobacillus rhamnosus CCFM1044 and Lactobacillus casei CCFM711, whose effect of alleviating metabolic syndrome is significantly better than that of CCFM8630 or CCFM8631 alone or combination of the two, especially in aspects of lowering contents of serum low density lipoprotein, total cholesterol, and liver triglyceride and contents of serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and IFN-?, and increasing contents of liver glutathione and superoxide dismutase, etc. The extent of decrease or increase is increased by 7.91% to 837.31% compared with the formulations of CCFM8630 or CCFM8631 alone or combination of the two probiotics. The combination of the four probiotics can achieve a significant synergistic effect.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: September 20, 2022
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Fangli Ma, Wei Chen, Gang Wang, Xiaofeng Zhu, Yuanyuan Wang, Junyong Xiao, Hao Zhang, Jianxin Zhao
  • Patent number: 11357710
    Abstract: The present invention provides a solid mask and a preparation method thereof. The solid mask includes a hydrophobic substrate layer and a nanofiber layer, the nanofiber layer has a three-dimensional structure and is electro-spun onto the hydrophobic substrate layer through uniaxial electrostatic spinning technology, and the nanofiber layer is prepared by the following food-grade raw materials in parts by mass: 10 to 30 parts of gelatin, 1 to 30 parts of soya bean lecithin and 0.1 to 10 parts of a functional substance. The present invention provides a solid mask, using gelatin and soya bean lecithin as the framework. The nanofiber layer is a three-dimensional laminate made of fibers having a diameter of a few hundred nanometers. The nanofiber layer has a membrane structure similar to the extracellular matrix. The raw materials of the solid mask are all food-grade raw materials or natural extracts.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: June 14, 2022
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Junyong Xiao, Meiling Tai, Tingshen Zhang, Xiquan Yin
  • Patent number: 11291697
    Abstract: The present disclosure relates to the field of microbial technology, and discloses a probiotic composition and use thereof. The probiotic composition in the present disclosure is consisted of Bifidobacterium adolescentis CCFM8630, Lactobacillus reuteri CCFM8631 and Lactobacillus rhamnosus CCFM1044, whose effect of alleviating metabolic syndrome is significantly better than that of CCFM8630 or CCFM8631 alone or combination of the two, especially in aspects of lowering epididymal fat content, lowering fasting blood glucose level, lowering the area under sugar tolerance curve and lowering contents of serum low density lipoprotein and total cholesterol, improving liver antioxidant capacity and lowering serum IL-1? content, etc. The extent of decrease or increase is increased by 9.62% to 769.62% compared with formulations of a single probiotic or a combination of two probiotics. The combination of three probiotics achieves a significant synergistic effect.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: April 5, 2022
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Yuanyuan Wang, Wei Chen, Gang Wang, Xiaofeng Zhu, Fangli Ma, Junyong Xiao, Hao Zhang, Jianxin Zhao
  • Patent number: 11224630
    Abstract: The present invention relates to the field of health care food technology, specifically to a traditional Chinese medicine composition with a function of protecting joints, a use thereof, a method for producing the same and a health care food thereof. The Chinese medicine composition comprises CURCUMAE LONGAE RHIZOMA extract, cartilage extract, COICIS SEMEN extract and PUERARIAE LOBATAE RADIX extract. The composition of the present disclosure has a reasonable formulation, and the ingredients cooperate with each other to achieve functions of reducing arthrocele degree, decreasing arthritis index, ameliorating biochemical index of arthritis and reducing articular cavity area through various paths and at various levels.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: January 18, 2022
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Liugang Ding, Zhongbao Yue, Danlin He, Yong Zhou, Jian Tang
  • Patent number: 11198892
    Abstract: Provided is a method of producing an oil containing polyunsaturated fatty acids by using Schizochytrium sp. The method comprises: performing fermentation using Schizochytrium sp.; resuspending the resultant cells after fermentation in water, adding cellulase and neutral protease for enzymolysis; mixing the enzymatic hydrolyzate with n-hexane, shaking, extracting, centrifuging, and collecting the n-hexane phase; concentrating the n-hexane phase under reduced pressure to remove the n-hexane, and drying to obtain an oil; performing a first crystallization and a second crystallization, and then performing cold filtration to obtain a liquid oil after the second crystallization; and subjecting the liquid oil to deacidification and decolorization. By regulating fermentation conditions and conducting concentration processing on polyunsaturated fatty acids, the content of eicosapentaenoic acid in the Schizochytrium sp.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: December 14, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Zehua Chen, Yong Zhou, Jian Tang, Yonghua Wang, Zheng Xiao, Chenfeng Jing, Dong Liang
  • Patent number: 11129863
    Abstract: The present disclosure relates to the technical field of traditional Chinese medicine technology, especially to a composition, a preparation method thereof and an application in the prevention and treatment of mammary gland diseases. The present disclosure provides a composition consisting of Rehmanniae Radix Praeparata, Lycii Fructus, Polygonati Rhizoma, Radix Codonopsis Pilosulae, Paeoniae Radix Alba, Cyperi Rhizoma (processed with vinegar) and Grape Seed. The composition has functions of improving hyperplasia of mammary gland and/or anti-oxidation. Compared with each control group, the composition provided by the present disclosure has the optimal effects, and the effect has statistical differences, indicating that the components in the composition provided by the present disclosure are reasonably arranged and can play a good synergistic effect. Furthermore, the preparation is safe and has no side effects.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: September 28, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Yu Wang, Chujie Li, Yiting Yang
  • Publication number: 20210177708
    Abstract: The present invention provides a solid mask and a preparation method thereof. The solid mask includes a hydrophobic substrate layer and a nanofiber layer, the nanofiber layer has a three-dimensional structure and is electro-spun onto the hydrophobic substrate layer through uniaxial electrostatic spinning technology, and the nanofiber layer is prepared by the following food-grade raw materials in parts by mass: 10 to 30 parts of gelatin, 1 to 30 parts of soya bean lecithin and 0.1 to 10 parts of a functional substance. The present invention provides a solid mask, using gelatin and soya bean lecithin as the framework. The nanofiber layer is a three-dimensional laminate made of fibers having a diameter of a few hundred nanometers. The nanofiber layer has a membrane structure similar to the extracellular matrix. The raw materials of the solid mask are all food-grade raw materials or natural extracts.
    Type: Application
    Filed: April 9, 2020
    Publication date: June 17, 2021
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Junyong XIAO, Meiling TAI, Tingshen ZHANG, Xiquan YIN
  • Patent number: 11026988
    Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising Lycii fructus polysaccharide, Polygonati rhizoma polysaccharide, Caryophylli flos oil and Cinnamomi cortex oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-? 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: June 8, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Fangli Ma, Yuanyuan Wang, Minghua Hu, Renhuai Cong, Lingyun Xiao, Chung Wah Ma
  • Publication number: 20210137823
    Abstract: A skin whitening program, comprising an external application step, a treatment step and an oral administration step. A skin care product for external application is selected from a whitening, brightening or yellow-removing skin care product, the effective ingredient in the skin care product being selected from a tricholoma matsutake, carthamus tinctorius or rhodiola rosea extract, a tricholoma matsutake, glycyrrhiza uralensis or pearl extract, or a panax notoginseng, salvia miltiorrhiza or radix astragali extract. A beautifying device for treatment is selected from an iontophoresis, microcurrent or LED green light beautifying device.
    Type: Application
    Filed: May 16, 2017
    Publication date: May 13, 2021
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Jian TANG, Yafei CHEN, Yanshan LIANG
  • Publication number: 20210106642
    Abstract: The present invention relates to a composition having an anti-glycation effect and an application thereof. The anti-glycation composition includes the following constituents in parts by mass: 0.1 to 5 parts of Osmanthus fragrans extract, 0.1 to 5 parts of Punica granatum extract and 0.1 to 2 part of Olea europaea extract, wherein in the Osmanthus fragrans extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of verbascoside is more than or equal to 10%; in the Punica granatum extract, a mass content of polyphenol is more than or equal to 30%, and a mass content of punicalagin is more than or equal to 8%; and in the Olea europaea extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of hydroxytyrosol is more than or equal to 3%.
    Type: Application
    Filed: December 11, 2019
    Publication date: April 15, 2021
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Xiaoling WANG, Huawei ZHU, Zhen LUO, Jian TANG
  • Patent number: 10967016
    Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, MORINDAE OFFICINALIS RADIX polysaccharide, POLYGONATI RHIZOMA polysaccharide, ANGELICAE SINENSIS RADIX oil and MYRISTICAE SEMEN oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, enhances body immune function, restores normal immune surveillance function, decreases VEGF and TGF-?1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: April 6, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Yuanyuan Wang, Fangli Ma, Renhuai Cong, Minghua Hu, Chung Wah Ma
  • Patent number: 10968495
    Abstract: Provided is a strain CCFM8631 of Lactobacillus reuteri and use thereof. The strain CCFM8631 of Lactobacillus reuteri can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Blautia genus and Turicibacter genus, Oscillospira genus and Bifidobacterium genus in intestinal flora of rat affected by high-fat high-starch diet, show good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: April 6, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Fangli Ma, Wei Chen, Gang Wang, Guangsu Zhu, Yuanyuan Wang, Lingyun Xiao, Minghua Hu, Hao Zhang, Jianxin Zhao, Chung Wah Ma
  • Patent number: 10967017
    Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, GRIFOLA FRONDOSA polysaccharide, ANGELICAE SINENSIS RADIX oil and CINNAMOMI CORTEX oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-? 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: April 6, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Minghua Hu, Fangli Ma, Yuanyuan Wang, Chung Wah Ma, Renhuai Cong, Lingyun Xiao
  • Patent number: 10960044
    Abstract: The present disclosure relates to the field of health care products, disclosing a powder made from inulin, FOLIUM CYCLOCARYA PALIURUS, RHIZOMA DIOSCOREA OPPOSITE, RADIX ASTRAGALUS MEMBRANACEUS, CAULIS DENDROBIUM and RADIX ET RHIZOMA SALVIA MILTIORRHIZA. The raw materials of the powder are all from natural Chinese herbal medicine without addition of excipient. In addition, dosage required for the powder is small; it can be directly dissolved in water for taking; it is soluble in cold water and can be absorbed quickly. The method for preparing the powder in the present disclosure is simple and suitable for large-scale production. Also, it is easy to be carried. The powder obtained has a good stability and long storage time. Experiments show that the powder of the present disclosure has greatly hypoglycemic and hypolipidemic effects, therefore can be used to prepare the health care foods having hypoglycemic and hypolipidemic effect.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: March 30, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Fang Lv, Hongwei Zhao, Qingtao Tang